APOTHEEK STROOMBANK: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
APOTHEEK STROOMBANK
Largest movements
- Current investments +€45,000
up €45,000 (+54.5%), from €82,500 to €127,500
- Stocks and contracts +€10,953
up €10,953 (+13.8%), from €79,372 to €90,325
- Cash +€7,254
up €7,254 (+11.3%), from €64,284 to €71,538
mainly Net result for the year (+€59,152) and Other debts (+€8,286)
- Receivables within one year +€5,281
up €5,281 (+16.9%), from €31,182 to €36,463
of which Trade receivables: +€7,950
- Reserves +€49,588
up €49,588 (+22.0%), from €225,305 to €274,893
- Other debts +€8,286
up €8,286 (+470%), from €1,765 to €10,051
- Trade debts +€4,038
up €4,038 (+22.1%), from €18,281 to €22,319
- Gross operating margin +€14,021
up €14,021 (+15.3%), from €91,557 to €105,578
- Taxes +€3,790
up €3,790 (+15.0%), from €25,215 to €29,006
- Write-downs +€2,390
up €2,390 (+44.7%), from €5,351 to €7,741
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €269,150 | €333,286 | +€64,136 | +23.8% |
| Fixed assets | 21/28 | €7,616 | €5,653 | -€1,962 | -25.8% |
| Tangible fixed assets | 22/27 | €5,366 | €3,403 | -€1,962 | -36.6% |
| Plant, machinery and equipment | 23 | €5,366 | €3,403 | -€1,962 | -36.6% |
| Financial fixed assets | 28 | €2,250 | €2,250 | = | 0.0% |
| Current assets | 29/58 | €261,534 | €327,633 | +€66,099 | +25.3% |
| Stocks and contracts in progress | 3 | €79,372 | €90,325 | +€10,953 | +13.8% |
| Stocks | 30/36 | €79,372 | €90,325 | +€10,953 | +13.8% |
| Amounts receivable within one year | 40/41 | €31,182 | €36,463 | +€5,281 | +16.9% |
| Trade receivables | 40 | €22,086 | €30,036 | +€7,950 | +36.0% |
| Other amounts receivable | 41 | €9,096 | €6,427 | -€2,669 | -29.3% |
| Current investments | 50/53 | €82,500 | €127,500 | +€45,000 | +54.5% |
| Cash at bank and in hand | 54/58 | €64,284 | €71,538 | +€7,254 | +11.3% |
| Deferred charges and accrued income | 490/1 | €4,197 | €1,807 | -€2,390 | -56.9% |
| Total equity and liabilities | 10/49 | €269,150 | €333,286 | +€64,136 | +23.8% |
| Equity | 10/15 | €243,905 | €293,493 | +€49,588 | +20.3% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €225,305 | €274,893 | +€49,588 | +22.0% |
| Distributable reserves | 133 | €225,305 | €274,893 | +€49,588 | +22.0% |
| Amounts payable | 17/49 | €25,245 | €39,793 | +€14,548 | +57.6% |
| Amounts payable within one year | 42/48 | €24,775 | €39,793 | +€15,019 | +60.6% |
| Trade debts | 44 | €18,281 | €22,319 | +€4,038 | +22.1% |
| Suppliers | 440/4 | €18,281 | €22,319 | +€4,038 | +22.1% |
| Taxes, remuneration and social security | 45 | €4,729 | €7,423 | +€2,695 | +57.0% |
| Taxes | 450/3 | €4,729 | €7,178 | +€2,450 | +51.8% |
| Remuneration and social security | 454/9 | - | €245 | +€245 | |
| Other amounts payable | 47/48 | €1,765 | €10,051 | +€8,286 | +470% |
| Accrued charges and deferred income | 492/3 | €470 | - | -€470 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,762 | €1,962 | +€200 | +11.4% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €5,351 | €7,741 | +€2,390 | +44.7% |
| Other operating charges | 640/8 | €1,034 | €1,027 | -€7 | -0.7% |
| Gross operating margin | 9900 | €91,557 | €105,578 | +€14,021 | +15.3% |
| Operating profit (loss) | 9901 | €83,410 | €94,847 | +€11,438 | +13.7% |
| Financial income | 75/76B | €3,967 | €3,373 | -€593 | -15.0% |
| Recurring financial income | 75 | €3,967 | €3,373 | -€593 | -15.0% |
| Financial charges | 65/66B | €10,250 | €10,063 | -€187 | -1.8% |
| Recurring financial charges | 65 | €10,250 | €10,063 | -€187 | -1.8% |
| Profit (loss) for the period before taxes | 9903 | €77,126 | €88,158 | +€11,031 | +14.3% |
| Income taxes | 67/77 | €25,215 | €29,006 | +€3,790 | +15.0% |
| Profit (loss) for the period | 9904 | €51,911 | €59,152 | +€7,241 | +13.9% |
| Profit (loss) for the period to be appropriated | 9905 | €51,911 | €59,152 | +€7,241 | +13.9% |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.